Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence87
Cost analyses for malaria molecular diagnosis for research planners in India and beyond69
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment65
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer50
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA42
What makes a « good » companion diagnostic in thoracic oncology?35
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features33
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma31
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects31
Polygenic and Network-based studies in risk identification and demystification of cancer30
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study29
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer29
Nuclease activity: an exploitable biomarker in bacterial infections27
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis27
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer27
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling25
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination25
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome24
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma23
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?22
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma22
The MALAT1-breast cancer interplay: insights and implications21
The current and future applications of in situ hybridization technologies in anatomical pathology21
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study21
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology21
0.10440182685852